CareRay Digital Medical Technology Valuation
Is 688607 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 688607 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 688607's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 688607's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 688607?
Other financial metrics that can be useful for relative valuation.
| What is 688607's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | CN¥1.14b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2x |
| Enterprise Value/EBITDA | 27.6x |
| PEG Ratio | 1.6x |
Price to Earnings Ratio vs Peers
How does 688607's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 93.2x | ||
300753 Jiangsu Apon Medical Technology | 181.8x | n/a | CN¥1.5b |
688067 AVE Science&TechnologyLTD | 52.6x | n/a | CN¥1.1b |
300562 Guangdong Transtek Medical Electronics | 33.9x | 17.3% | CN¥2.0b |
688329 Suzhou Iron TechnologyLTD | 104.7x | n/a | CN¥1.4b |
688607 CareRay Digital Medical Technology | 48.4x | 30.4% | CN¥1.1b |
Price-To-Earnings vs Peers: 688607 is good value based on its Price-To-Earnings Ratio (48.4x) compared to the peer average (93.2x).
Price to Earnings Ratio vs Industry
How does 688607's PE Ratio compare vs other companies in the CN Medical Equipment Industry?
Price-To-Earnings vs Industry: 688607 is expensive based on its Price-To-Earnings Ratio (48.4x) compared to the CN Medical Equipment industry average (30.5x).
Price to Earnings Ratio vs Fair Ratio
What is 688607's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 48.4x |
| Fair PE Ratio | 25.4x |
Price-To-Earnings vs Fair Ratio: 688607 is expensive based on its Price-To-Earnings Ratio (48.4x) compared to the estimated Fair Price-To-Earnings Ratio (25.4x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.